Research
Hormonal
Semaglutide 2.4 mg once weekly significantly reduces body weight by approximately 15%, with simultaneous improvement in cardiometabolic risk factors and physical functioning in people with obesity.
Practitioners can consider semaglutide as an effective treatment option for weight loss in obese patients.
StrongSupportsmedium confidence
Semaglutide 2.4 mg once weekly significantly reduces body weight by approximately 15%, with simultaneous improvement in cardiometabolic risk factors and physical functioning in people with obesity.
Why this rating
The claim is based on recent clinical findings regarding a specific medication.
Source
New insights into the treatment of obesity
Matthias Blüher et al. · Diabetes Obesity and Metabolism · 2023
reviewCited 142×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →